Skip to main content
Clinical Trials/NCT00419627
NCT00419627
Unknown
Not Applicable

Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.

Hillel Yaffe Medical Center1 site in 1 country160 target enrollmentFebruary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Neoplasms
Sponsor
Hillel Yaffe Medical Center
Enrollment
160
Locations
1
Last Updated
19 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response

Detailed Description

The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors. Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence. Real specimens will be evaluated using PCR and mass spectrometry.

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
TBD
Last Updated
19 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas

Exclusion Criteria

  • Withdrawal of consent
  • Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials